Man Group »

Cerevel Therapeutics Hldng I shares owned by Man Group

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Man Group from 13F filings

Historical chart of Man Group investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Man Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Man Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.9M 92k 42.40
2023-06-30 $4.8M 152k 31.79
2022-06-30 $322k 12k 26.47
2021-03-31 $185k 14k 13.74

More positions owned by Man Group

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Coca-Cola Company (KO)
Anthem (ELV)
Qualcomm (QCOM)
Newmont Mining Corporation (NEM)
Intel Corporation (INTC)
Adobe Systems Incorporated (ADBE)

View all positions for Man Group

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I